THE PRECISION ONCOLOGY CRO Trademark

Trademark Overview


On Thursday, January 13, 2022, a trademark application was filed for THE PRECISION ONCOLOGY CRO with the United States Patent and Trademark Office. The USPTO has given the THE PRECISION ONCOLOGY CRO trademark a serial number of 97218239. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by TRANSLATIONAL DRUG DEVELOPMENT, LLC. The THE PRECISION ONCOLOGY CRO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services for others in the field of design, planning, and implementation of project management for scientific research, clinical trials, and statistical analyses in the field of oncology; Scientific research, namely, conducting pre-clinical trials and supporting clinical trials for others; Providing scientific research information in the field of pre-clinical testing; Pharmaceutical drug development and related services, namely, pharmaceutical products development and pharmaceutical research services
the precision oncology cro

General Information


Serial Number97218239
Word MarkTHE PRECISION ONCOLOGY CRO
Filing DateThursday, January 13, 2022
Status700 - REGISTERED
Status DateTuesday, August 22, 2023
Registration Number7141907
Registration DateTuesday, August 22, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements


Goods and ServicesConsulting services for others in the field of design, planning, and implementation of project management for scientific research, clinical trials, and statistical analyses in the field of oncology; Scientific research, namely, conducting pre-clinical trials and supporting clinical trials for others; Providing scientific research information in the field of pre-clinical testing; Pharmaceutical drug development and related services, namely, pharmaceutical products development and pharmaceutical research services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 20, 2022
Primary Code042
First Use Anywhere DateThursday, February 20, 2014
First Use In Commerce DateSaturday, April 26, 2014

Trademark Owner History


Party NameTRANSLATIONAL DRUG DEVELOPMENT, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressScottsdale, AZ 85259

Party NameTRANSLATIONAL DRUG DEVELOPMENT, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressScottsdale, AZ 85259

Party NameTRANSLATIONAL DRUG DEVELOPMENT, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressScottsdale, AZ 85259

Trademark Events


Event DateEvent Description
Monday, January 17, 2022NEW APPLICATION ENTERED
Thursday, January 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 19, 2022ASSIGNED TO EXAMINER
Monday, October 24, 2022NON-FINAL ACTION WRITTEN
Monday, October 24, 2022NON-FINAL ACTION E-MAILED
Monday, October 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 22, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, July 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 24, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 24, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED